An investigation into the causes found that fewer than 1% of the FDA’s drug recalls are from CVS’ generic drugs, but several of the company’s drug recalls have been linked to the qualities of factories it uses for manufacturing its generic medications.
A spokesperson for CVS told Bloomberg that it selects factories based on “good manufacturing and ethical sourcing practices and the ability to meet our strict standards and testing practices.”
In the last decade, CVS has used at least 15 manufacturers that were cited for manufacturing problems which led to recalls of 133 recalls of its generic-brand drugs, which is twice as many as those of Walgreens, Bloomberg reported.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
